Oscar Health, Inc. announced its financial results for the first quarter ended March 31, 2024, with total revenue of $2.1 billion, a 46% increase year-over-year. The company reported a net income attributable to Oscar of $177.4 million, or $0.62 of diluted earnings per share.
Total Revenue was $2.1 billion, up 46% year-over-year.
Medical Loss Ratio improved to 74.2%, a 210 bps improvement year-over-year.
SG&A Expense Ratio significantly improved to 18.4%, an 870 bps improvement year-over-year.
Net Income attributable to Oscar was $177.4 million, a significant improvement of $217.1 million year-over-year.
Oscar is reaffirming its full year 2024 outlook across all metrics as provided in its financial results press release dated February 7, 2024.